文献速递免疫规划传染病防控与疫情报告

BNT162b2疫苗接种后6个月疫苗诱导的SARS-CoV-2体液免疫应答显著下降但细胞免疫可能保留

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination.
PubMed 文献 · Vaccine · 2022-03-29

该研究评估了98名健康受试者完成两剂BNT162b2疫苗接种后6个月的体液免疫和细胞免疫。SP IgG和NT50几何平均滴度分别从接种后3周的95.2和680.4下降至6个月的5.7和130.4。尽管疫苗诱导的抗体水平显著下降,但无论年龄如何,均观察到一定程度的细胞免疫。

要点

  • 接种后6个月SP IgG和NT50几何平均滴度较3周时显著下降。
  • SP IgG滴度与年龄和饮酒量呈负相关。
  • 6个月时斑点形成细胞计数与年龄、性别等参数无关。

核心结论

  • 尽管疫苗接种后6个月疫苗诱导的抗体水平显著下降,但无论年龄如何,均观察到一定程度的细胞免疫。

研究设计与样本

  • 研究纳入98名健康受试者(中位年龄43岁),在完成两剂BNT162b2疫苗接种后3周和6个月时,通过干扰素-γ释放ELISpot试验评估SP IgG、NT50和斑点形成细胞计数。

主要发现

  • SP IgG几何平均滴度从接种后3周的95.2(95%CI 79.8-113.4)下降至6个月的5.7(95%CI 4.9-6.7)。
  • NT50几何平均滴度从接种后3周的680.4(95%CI 588.0-787.2)下降至6个月的130.4(95%CI 104.2-163.1)。
  • SP IgG滴度与年龄和饮酒量呈负相关。
  • 6个月时斑点形成细胞计数与年龄、性别及其他患者参数无关。
  • 突破感染受试者的SP IgG、NT50和斑点形成细胞滴度均升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To evaluate vaccine-induced humoral and cell-mediated immunity at 6 months after completion of two doses of BNT162b2 vaccination, immunoglobulin G against SARS-CoV-2 spike protein (SP IgG), 50% neutralizing antibody (NT50), and spot-forming cell (SFC) counts were evaluated by interferon-γ releasing ELISpot assay of 98 healthy subjects (median age, 43 years). The geometric mean titers of SP IgG and NT50 decreased from 95.2 (95% confidence interval (CI) 79.8-113.4) to 5.7 (95% CI 4.9-6.7) and from 680.4 (588.0-787.2) to 130.4 (95% CI 104.2-163.1), respectively, at 3 weeks and 6 months after the vaccination. SP IgG titer was negatively correlated with age and alcohol consumption. Spot-forming cell counts at 6 months did not correlate with age, gender, and other parameters of the patients. SP IgG, NT50, and SFC titers were elevated in the breakthrough infected subjects. Although the levels of vaccine-induced antibodies dramatically declined at 6 months after vaccination, a certain degree of cellular immunity was observed irrespective of the age.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kato H, Miyakawa K, Ohtake N, et al. Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination. Vaccine. 2022. PMID: 35370020. doi:10.1016/j.vaccine.2022.03.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。